hi abmat, I am hopeful that the company raises the required funds. Avenira has so much potential and finally the chance to deliever on it.
i have contacted the company but haven’t heard anything.
in my opinion the best result for all shareholders is for avenira to be successful in its current state.
avenira has historically had some loose holders and the volumes arent really that big.
novaphos being commercial opens up so many opportunities at wonarah and baoibab.
lets hope we can get on a good run for all holders.
we deserve it
- Forums
- ASX - By Stock
- AEV
- Ann: Funding Update
Ann: Funding Update, page-16
Featured News
Add AEV (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
-0.001(5.26%) |
Mkt cap ! $24.33M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.9¢ | $3.752K | 416.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2796798 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 300000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2796798 | 0.009 |
7 | 720000 | 0.008 |
4 | 1442142 | 0.007 |
8 | 21007328 | 0.006 |
2 | 1500001 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 300000 | 1 |
0.011 | 1783566 | 5 |
0.012 | 659923 | 6 |
0.013 | 152257 | 2 |
0.014 | 2440000 | 5 |
Last trade - 13.54pm 12/11/2024 (20 minute delay) ? |
Featured News
AEV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online